Basket

  1. 1.
    0556801 - BTÚ 2023 RIV GB eng J - Journal Article
    Vačurová, Eliška - Trnovská, J. - Svoboda, P. - Skop, V. - Novosadová, Vendula - Reguera, David Pajuelo - Petrezselyova, Silvia - Piavaux, Benoit - Endaya, Berwini - Špoutil, František - Zudová, Dagmar - Štursa, Jan - Melčová, M. - Bielcikova, Z. - Werner, Lukáš - Procházka, Jan - Sedláček, Radislav - Hüttl, M. - Štemberková-Hubáčková, Soňa - Haluzík, M. - Neužil, Jiří
    Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice.
    Nature Communications. Roč. 13, č. 1 (2022), č. článku 1866. E-ISSN 2041-1723
    R&D Projects: GA ČR(CZ) GA18-02550S; GA ČR(CZ) GA18-10832S; GA ČR(CZ) GA20-05942S; GA ČR(CZ) GX21-04607X; GA MZd(CZ) NV17-30138A; GA MŠMT(CZ) LM2015062; GA MŠMT(CZ) EF16_013/0001775
    Research Infrastructure: Czech-BioImaging - 90062
    Institutional support: RVO:86652036 ; RVO:68378050
    Keywords : mitotic clonal expansion * body-composition changes * adipose-tissue * cellular senescence * insulin-resistance
    OECD category: Endocrinology and metabolism (including diabetes, hormones)
    Impact factor: 16.6, year: 2022
    Method of publishing: Open access
    https://www.nature.com/articles/s41467-022-29486-z
    Permanent Link: http://hdl.handle.net/11104/0331426
     
     

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.